JP2016501882A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501882A5
JP2016501882A5 JP2015545854A JP2015545854A JP2016501882A5 JP 2016501882 A5 JP2016501882 A5 JP 2016501882A5 JP 2015545854 A JP2015545854 A JP 2015545854A JP 2015545854 A JP2015545854 A JP 2015545854A JP 2016501882 A5 JP2016501882 A5 JP 2016501882A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
hydrogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015545854A
Other languages
English (en)
Japanese (ja)
Other versions
JP6256771B2 (ja
JP2016501882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/073424 external-priority patent/WO2014089364A1/en
Publication of JP2016501882A publication Critical patent/JP2016501882A/ja
Publication of JP2016501882A5 publication Critical patent/JP2016501882A5/ja
Application granted granted Critical
Publication of JP6256771B2 publication Critical patent/JP6256771B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015545854A 2012-12-06 2013-12-05 ヒストンデメチラーゼ阻害剤 Active JP6256771B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261734330P 2012-12-06 2012-12-06
US61/734,330 2012-12-06
US201361784414P 2013-03-14 2013-03-14
US61/784,414 2013-03-14
PCT/US2013/073424 WO2014089364A1 (en) 2012-12-06 2013-12-05 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2016501882A JP2016501882A (ja) 2016-01-21
JP2016501882A5 true JP2016501882A5 (US20070167479A1-20070719-C00034.png) 2016-12-01
JP6256771B2 JP6256771B2 (ja) 2018-01-10

Family

ID=50884011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545854A Active JP6256771B2 (ja) 2012-12-06 2013-12-05 ヒストンデメチラーゼ阻害剤

Country Status (7)

Country Link
US (7) US9604961B2 (US20070167479A1-20070719-C00034.png)
EP (2) EP3763367A1 (US20070167479A1-20070719-C00034.png)
JP (1) JP6256771B2 (US20070167479A1-20070719-C00034.png)
CA (1) CA2894399A1 (US20070167479A1-20070719-C00034.png)
ES (1) ES2834959T3 (US20070167479A1-20070719-C00034.png)
MX (1) MX2015007205A (US20070167479A1-20070719-C00034.png)
WO (1) WO2014089364A1 (US20070167479A1-20070719-C00034.png)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2903968T3 (pl) 2012-10-02 2017-05-31 Gilead Sciences, Inc. Inhibitory demetylaz histonowych
WO2014089364A1 (en) 2012-12-06 2014-06-12 Quanticel Pharmaceuticals, Inc Histone demethylase inhibitors
JP6514117B2 (ja) 2013-02-27 2019-05-15 エピセラピューティクス アーペーエス ヒストン脱メチル化酵素の阻害剤
JP2017066030A (ja) * 2014-02-04 2017-04-06 アグロカネショウ株式会社 新規なピラゾール誘導体およびこれを有効成分とする農園芸用薬剤
CA2946538A1 (en) 2014-04-04 2015-10-08 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
MX2016017407A (es) 2014-06-25 2017-04-27 Celgene Quanticel Res Inc Inhibidores de histona demetilasa.
RU2712192C2 (ru) 2014-07-31 2020-01-24 Басф Се Способ получения пиразолов
JP6689821B2 (ja) 2014-08-12 2020-04-28 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する殺有害生物的に活性な複素環式誘導体
EA201790154A1 (ru) 2014-08-27 2017-08-31 Джилид Сайэнс, Инк. Соединения и способы для ингибирования гистоновых деметилаз
MX2017003464A (es) * 2014-09-16 2017-07-13 Celgene Quanticel Res Inc Inhibidores de histona desmetilasa.
US9896436B2 (en) 2014-09-16 2018-02-20 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
PE20180327A1 (es) 2015-05-11 2018-02-13 Basf Se Proceso para preparar 4-amino-piridazinas
BR112018014357B8 (pt) 2016-02-02 2022-09-06 Basf Se Processo para a preparação de um composto de pirazol e composição
WO2017143011A1 (en) * 2016-02-16 2017-08-24 Chrysalis, Inc. Histone demethylase inhibitors
EP3436445B1 (en) * 2016-03-15 2023-09-06 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017198785A1 (en) * 2016-05-18 2017-11-23 Ieo - Istituto Europeo Di Oncologia S.R.L. Oxime derivatives useful as inhibitors of histone demethylase kdm4c
BR102017010009A2 (pt) 2016-05-27 2017-12-12 Gilead Sciences, Inc. Compounds for the treatment of hepatitis b virus infection
MX2018014377A (es) 2016-05-27 2019-03-14 Gilead Sciences Inc Metodos para tratar infecciones por virus de hepatitis b usando inhibidores de proteina no estructural 5a (ns5a), proteina no estructural 5b (ns5b) o proteina no estructural 3 (ns3).
WO2017207813A1 (en) 2016-06-03 2017-12-07 Oryzon Genomics, S.A. Heteroaryl-carboxylic acids as histone demethylase inhibitors
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
WO2018045144A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Toll like receptor modulator compounds
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
CR20190181A (es) 2016-10-14 2019-08-21 Prec Biosciences Inc Meganucleasas diseñadas específicamente para el reconocimiento de secuencias en el genoma del virus de la hepatitis b.
TWI784370B (zh) 2017-01-31 2022-11-21 美商基利科學股份有限公司 替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
JOP20180008A1 (ar) 2017-02-02 2019-01-30 Gilead Sciences Inc مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
JOP20180040A1 (ar) 2017-04-20 2019-01-30 Gilead Sciences Inc مثبطات pd-1/pd-l1
WO2018219478A1 (en) 2017-06-02 2018-12-06 Oryzon Genomics, S.A. Heteroaryl-carboxamides as histone demethylase inhibitors
AU2018392213B2 (en) 2017-12-20 2021-03-04 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 3'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
CN111511754B (zh) 2017-12-20 2023-09-12 捷克共和国有机化学与生物化学研究所 活化sting转接蛋白的具有膦酸酯键的2’3’环状二核苷酸
AU2019222644B2 (en) 2018-02-13 2021-04-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
KR102526964B1 (ko) 2018-02-26 2023-04-28 길리애드 사이언시즈, 인코포레이티드 Hbv 복제 억제제로서의 치환된 피롤리진 화합물
EP3774883A1 (en) 2018-04-05 2021-02-17 Gilead Sciences, Inc. Antibodies and fragments thereof that bind hepatitis b virus protein x
TWI833744B (zh) 2018-04-06 2024-03-01 捷克科學院有機化學與生物化學研究所 3'3'-環二核苷酸
TW202005654A (zh) 2018-04-06 2020-02-01 捷克科學院有機化學與生物化學研究所 2,2,─環二核苷酸
TWI818007B (zh) 2018-04-06 2023-10-11 捷克科學院有機化學與生物化學研究所 2'3'-環二核苷酸
US11142750B2 (en) 2018-04-12 2021-10-12 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
CN112041311B (zh) 2018-04-19 2023-10-03 吉利德科学公司 Pd-1/pd-l1抑制剂
WO2019211799A1 (en) 2018-05-03 2019-11-07 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
EP4234030A3 (en) 2018-07-13 2023-10-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
WO2020028097A1 (en) 2018-08-01 2020-02-06 Gilead Sciences, Inc. Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
EP3873903B1 (en) 2018-10-31 2024-01-24 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
US11071730B2 (en) 2018-10-31 2021-07-27 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
US11766447B2 (en) 2019-03-07 2023-09-26 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
CN113543851A (zh) 2019-03-07 2021-10-22 捷克共和国有机化学与生物化学研究所 2’3’-环二核苷酸及其前药
KR20210137518A (ko) 2019-03-07 2021-11-17 인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. 3'3'-사이클릭 다이뉴클레오티드 및 이의 프로드럭
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
WO2020237025A1 (en) 2019-05-23 2020-11-26 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
JP7237311B2 (ja) * 2019-06-06 2023-03-13 京都府公立大学法人 化合物、医薬組成物、kdm5c阻害剤及び抗うつ剤
CN110128347A (zh) * 2019-06-17 2019-08-16 韶远科技(上海)有限公司 一种1-甲基-1h-吲唑-6-甲酸的合成方法
CA3142513A1 (en) 2019-06-25 2020-12-30 Gilead Sciences, Inc. Flt3l-fc fusion proteins and methods of use
US20220257619A1 (en) 2019-07-18 2022-08-18 Gilead Sciences, Inc. Long-acting formulations of tenofovir alafenamide
WO2021034804A1 (en) 2019-08-19 2021-02-25 Gilead Sciences, Inc. Pharmaceutical formulations of tenofovir alafenamide
MX2022003658A (es) 2019-09-30 2022-04-25 Gilead Sciences Inc Vacunas contra el virus de la hepatitis b (vhb) y metodos para tratar el vhb.
WO2021113765A1 (en) 2019-12-06 2021-06-10 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
USD1000624S1 (en) 2019-12-27 2023-10-03 Thomas Nichols Personal care device with camera
WO2021188936A1 (en) * 2020-03-20 2021-09-23 Akebia Therapeutics, Inc. Phd inhibitor compounds, compositions, and use
JP2023518433A (ja) 2020-03-20 2023-05-01 ギリアード サイエンシーズ, インコーポレイテッド 4’-c-置換-2-ハロ-2’-デオキシアデノシンヌクレオシドのプロドラッグ並びにその製造法及び使用法
AU2021240044A1 (en) * 2020-03-20 2022-11-17 Akebia Therapeutics, Inc. PHD inhibitor compounds, compositions, and use
WO2021188944A1 (en) * 2020-03-20 2021-09-23 Akebia Therapeutics, Inc. Phd inhibitor compounds, compositions, and their use
PE20230779A1 (es) 2020-08-07 2023-05-09 Gilead Sciences Inc Profarmacos de analogos de nucleotidos de fosfonamida y su uso farmaceutico
WO2022063050A1 (zh) * 2020-09-28 2022-03-31 四川科伦博泰生物医药股份有限公司 吡唑类化合物及其制备方法和用途
TW202406932A (zh) 2020-10-22 2024-02-16 美商基利科學股份有限公司 介白素2-Fc融合蛋白及使用方法
TW202310852A (zh) 2021-05-13 2023-03-16 美商基利科學股份有限公司 TLR8調節化合物及抗HBV siRNA療法之組合
EP4359411A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
CN117396478A (zh) 2021-06-23 2024-01-12 吉利德科学公司 二酰基甘油激酶调节化合物
EP4359415A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
US11932634B2 (en) 2021-06-23 2024-03-19 Gilead Sciences, Inc. Diacylglycerol kinase modulating compounds
WO2024100791A1 (ja) * 2022-11-09 2024-05-16 株式会社日本ファインケム 1-アルキル-5-ヒドロキシピラゾールの製造方法

Family Cites Families (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68369C (fi) 1983-03-01 1985-09-10 Waertsilae Oy Ab Bestrykningsanordning
US4824859A (en) 1983-05-21 1989-04-25 Fisons Plc. Pyrazoline compounds compositions and use
FI855180A (fi) 1985-01-18 1986-07-19 Nissan Chemical Ind Ltd Pyrazolsulfonamidderivat, foerfarande foer dess framstaellande och det innehaollande ograesgift.
US4699647A (en) 1985-05-30 1987-10-13 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
DE3528477A1 (de) 1985-08-08 1987-02-19 Bayer Ag 1-aryl-pyrazole
DE3538731A1 (de) 1985-10-31 1987-05-07 Bayer Ag 1-aryl-4-nitro-pyrazole
DE3539844A1 (de) 1985-11-09 1987-05-14 Bayer Ag Substituierte 5-amino-1-aryl-pyrazole
DE3543035A1 (de) 1985-12-05 1987-06-11 Bayer Ag 5-fluoracylamino-4-nitro-1-aryl-pyrazole
DE3543034A1 (de) 1985-12-05 1987-06-11 Bayer Ag 5-perfluoracylamino-4-nitro-1-aryl-pyrazol-salze
DE3600950A1 (de) 1986-01-15 1987-07-16 Bayer Ag 5-acylamido-1-aryl-pyrazole
DE3609542A1 (de) 1986-03-21 1987-10-01 Bayer Ag 5-acylamino-pyrazol-derivate
DE3625686A1 (de) 1986-07-30 1988-02-04 Bayer Ag 4-cyano(nitro)-5-oxy(thio)-pyrazol-derivate
DE3628892A1 (de) 1986-08-26 1988-03-10 Bayer Ag Substituierte 1-aryl-3-tert.-butyl-pyrazole
DE3631003A1 (de) 1986-09-12 1988-03-24 Bayer Ag Verfahren zur herstellung von 4-substituierten 1-aryl-5-amino-pyrazolen
DE3637710A1 (de) 1986-11-05 1988-05-11 Bayer Ag 5-acylamino-pyrazol-derivate
DE3707551A1 (de) 1987-03-10 1988-09-22 Bayer Ag Substituierte 1-arylpyrazole
DE3721868A1 (de) 1987-07-02 1989-01-12 Bayer Ag 1-arylpyrazole
DE3911556A1 (de) 1989-04-08 1990-10-11 Bayer Ag Substituierte 1-arylpyrazole
DE4023488A1 (de) 1990-07-24 1992-01-30 Bayer Ag 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide
US5298368A (en) 1991-04-23 1994-03-29 Eastman Kodak Company Photographic coupler compositions and methods for reducing continued coupling
US5292844A (en) 1991-05-22 1994-03-08 Minnesota Mining And Manufacturing Company Vinyl acetate modified suspension polymer beads, adhesives made therefrom and a method of making
US5262284A (en) 1991-07-15 1993-11-16 Eastman Kodak Company Arylidene pyrazolone coupler
DE4126244A1 (de) 1991-08-08 1993-02-11 Bayer Ag Massefaerben von kunststoffen
US5250405A (en) 1991-08-29 1993-10-05 Eastman Kodak Company Color photographic materials including magenta coupler, inhibitor-releasing coupler and carbonamide compound, and methods
US5200309A (en) 1991-08-29 1993-04-06 Eastman Kodak Company Color photographic materials including magenta coupler, carbonamide compound and aniline or amine compound, and methods
US5376519A (en) 1992-04-23 1994-12-27 Eastman Kodak Company Photographic material containing a coupler composition comprising magenta coupler, phenolic solvent, and at least one aniline or amine
US5340707A (en) 1992-09-16 1994-08-23 Konica Corporation Silver halide photographic light-sensitive material
AU6536494A (en) 1993-03-26 1994-10-24 Shell Internationale Research Maatschappij B.V. Herbicidal 1-heteroaryl pyrazolidin-3,5-diones
US5389504A (en) 1993-06-24 1995-02-14 Eastman Kodak Company Color photographic elements containing a combination of pyrazolone and pyrazoloazole couplers
DE69522513T2 (de) 1994-06-23 2002-04-11 Eastman Kodak Co., Rochester Fotographische Zwei-Äquivalent-Purpurrot-Kuppler mit die Aktivität modifizierender Ballastgruppen
DE69622148T2 (de) 1995-09-28 2002-10-31 Suntory Limited, Osaka Chinazozin derivate und deren verwendung
JP2001508767A (ja) 1996-12-02 2001-07-03 藤沢薬品工業株式会社 5―ht拮抗作用を有するインドール―ウレア誘導体
US5821043A (en) 1996-12-30 1998-10-13 Eastman Kodak Company 1,2,4-triazole-releasing pyrazolone DIR couplers
ZA981934B (en) 1997-03-10 1999-09-06 Rhone Poulenc Agrochimie Pesticidal 1-aryl-3-iminopyrazoles.
US5958662A (en) 1997-03-25 1999-09-28 Eastman Kodak Company Photographic element containing a DIR coupler
US5942381A (en) 1997-06-12 1999-08-24 Eastman Kodak Company Photographic element and process employing active, stable benzotriazole-releasing DIR couplers
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
ATE234289T1 (de) 1997-09-05 2003-03-15 Basf Ag Verfahren zur herstellung (hetero)aromatischer hydroxylamine
DE19804486A1 (de) 1998-02-05 1999-08-12 Basf Ag 2-(Pyrazolyloxy)-pyridin-3-ylessigsäure- Derivate, sie enthaltende Mittel und ihr
US6121271A (en) 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
US6010839A (en) 1998-06-26 2000-01-04 Eastman Kodak Company Color photographic elements containing yellow-colored magenta dye-forming masking couplers
US20030191279A1 (en) 1999-08-27 2003-10-09 Goldstein Steven Wayne Urea derivatives useful as anticancer agents
US6132943A (en) 1999-10-14 2000-10-17 Eastman Kodak Company Color photographic elements containing yellow-colored magenta dye-forming masking couplers
JP2001335714A (ja) 2000-03-22 2001-12-04 Fuji Photo Film Co Ltd アゾ色素、その製造方法、インクジェット用インク、インクジェット記録方法
JP2003531202A (ja) 2000-04-25 2003-10-21 ファルマシア・コーポレーション 3,4−ジ(カルボシクリルまたはヘテロシクリル)チオフェンの位置選択的合成
JP4113323B2 (ja) 2000-08-07 2008-07-09 富士フイルム株式会社 アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
JP2002167531A (ja) 2000-11-29 2002-06-11 Fuji Photo Film Co Ltd インクジェット記録用インク組成物及び画像形成方法
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
US6603000B2 (en) 2001-07-11 2003-08-05 Boehringer Ingelheim Pharmaceuticals, Inc. Synthesis for heteroarylamine compounds
AU2002319814A1 (en) 2001-08-13 2003-03-03 E.I. Du Pont De Nemours And Company Substituted 1h-dihydropyrazoles, their preparation and use
TWI325302B (en) 2001-08-13 2010-06-01 Du Pont Benzoxazinone compounds
TWI327566B (en) 2001-08-13 2010-07-21 Du Pont Novel substituted ihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
MXPA04001407A (es) 2001-08-16 2004-05-27 Du Pont Antranilamidas sustituidas para controlar plagas de invertebrados.
SE0103644D0 (sv) 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic isoquinoline compounds
EP2033953A1 (en) 2002-02-15 2009-03-11 Glaxo Group Limited Vanilloid receptor modulators
DE60336739D1 (de) 2002-07-23 2011-05-26 Kuraray Co Verfahren zur herstellung eines 2-substituierten pyridinderivats
TWI343376B (en) 2002-07-31 2011-06-11 Du Pont Method for preparing 3-halo-4, 5-dihydro-1h-pyrazoles
TWI326283B (en) 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
PA8578101A1 (es) 2002-08-13 2004-05-07 Warner Lambert Co Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
US20060014815A1 (en) 2002-10-23 2006-01-19 Toshiaki Mase Process for making pyrazole compounds
ATE469143T1 (de) 2002-11-15 2010-06-15 Du Pont Neue insektizide vom anthranilamid-typ
ATE359782T1 (de) 2003-01-16 2007-05-15 Sb Pharmco Inc Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
EP1594512A4 (en) 2003-02-11 2007-07-11 Kemia Inc COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
TWI367882B (en) 2003-03-26 2012-07-11 Du Pont Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
KR20060008336A (ko) 2003-06-12 2006-01-26 이 아이 듀폰 디 네모아 앤드 캄파니 융합된 옥사지논 제조 방법
WO2005023773A1 (en) 2003-09-04 2005-03-17 Pfizer Limited Process for the preparation of substituted aryl pyrazoles
GB0323585D0 (en) 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
DE102004021564A1 (de) 2003-11-14 2005-07-07 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
DE10353281A1 (de) 2003-11-14 2005-06-16 Bayer Cropscience Ag Wirkstoffkombination mit insektiziden und akariziden Eigenschaften
DE102004006075A1 (de) 2003-11-14 2005-06-16 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
EP1691608B2 (de) 2003-12-04 2015-04-08 Bayer CropScience AG Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
DE10356550A1 (de) 2003-12-04 2005-07-07 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
US20070142327A1 (en) 2003-12-04 2007-06-21 Bayer Cropscience Aktiengesellschaft Active compound combinations having insecticidal properties
DE102004023635A1 (de) 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
CN1968922A (zh) 2004-06-18 2007-05-23 米伦纽姆医药公司 因子xa抑制剂
DE102004031100A1 (de) 2004-06-28 2006-01-12 Bayer Cropscience Ag Anthranilamide
DE102004035134A1 (de) 2004-07-20 2006-02-16 Bayer Cropscience Ag Selektive Insektizide auf Basis von Halogenalkylnicotinsäurederivaten, Anthranilsäureamiden oder Phthalsäurediamiden und Safenern
CA2578122A1 (en) 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives
EP1815206B1 (en) 2004-10-13 2016-04-06 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
US20080119505A1 (en) 2005-02-01 2008-05-22 Altana Pharma Ag Novel 6-Pyridylphenanthridines
EA200701815A1 (ru) 2005-03-02 2008-02-28 Никомед Гмбх 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний
EP1728790A1 (en) 2005-06-01 2006-12-06 Max-Delbrück-Centrum Für Molekulare Medizin Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
BRPI0613535A2 (pt) 2005-06-02 2011-01-18 Bayer Cropscience Ag derivados de heteroarila substituìda por fenilalquila
ATE455103T1 (de) 2005-06-24 2010-01-15 Bristol Myers Squibb Co Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
DK1904475T3 (da) 2005-07-07 2011-11-21 Basf Se N-thioanthranilamid-forbindelser og deres anvendelse som pesticider
WO2007131538A1 (en) 2005-07-15 2007-11-22 Laboratorios Del Dr. Esteve, S.A. Azepane- or azocane-substituted pyrazoline compounds, their preparation and use as medicaments
US7531482B2 (en) 2005-10-21 2009-05-12 Dow Agrosciences Llc Thieno-pyrimidine compounds having fungicidal activity
EP2078721B1 (en) 2005-10-21 2014-01-22 Dow AgroSciences LLC Thieno-pyrimidine compounds having fungicidal activity
EP1954276A2 (en) 2005-11-22 2008-08-13 Merck & Co., Inc. Indole orexin receptor antagonists
WO2007063868A1 (ja) 2005-11-29 2007-06-07 Toray Industries, Inc. アリールメチレンウレア誘導体及びその用途
EP1959959B1 (en) 2005-12-06 2013-04-10 Merck Sharp & Dohme Corp. Morpholine carboxamide prokineticin receptor antagonists
DE102005059470A1 (de) 2005-12-13 2007-06-14 Bayer Cropscience Ag Insektizide Zusammensetzungen mit verbesserter Wirkung
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
KR101325062B1 (ko) 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자
TW200817375A (en) 2006-07-21 2008-04-16 Irm Llc Compounds and compositions as ITPKB inhibitors
WO2008023235A1 (en) 2006-08-25 2008-02-28 Pfizer Products Inc. Pyrazole derivatives as anti-platelet and anti-thrombotic agents
ES2559521T3 (es) 2006-10-16 2016-02-12 Thesan Pharmaceuticals, Inc. Pirazolil tienopiridinas terapéuticas
KR20090094125A (ko) * 2006-12-08 2009-09-03 엑셀리시스, 인코포레이티드 Lxr 및 fxr 조절자
WO2008082487A2 (en) 2006-12-20 2008-07-10 Schering Corporation Novel jnk inhibitors
EP1958934A1 (en) 2007-02-16 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
WO2008106202A1 (en) 2007-02-27 2008-09-04 Housey Gerard M Theramutein modulators
CA2682393C (en) 2007-04-11 2015-03-17 Kissei Pharmaceutical Co., Ltd. 5-membered heterocyclic derivative and use thereof for medical purposes
US8071035B2 (en) 2007-04-12 2011-12-06 Siemens Medical Solutions Usa, Inc. Microfluidic radiosynthesis system for positron emission tomography biomarkers
EP2148878A4 (en) 2007-04-20 2011-08-10 Merck Canada Inc NEW HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE
EP2148868A1 (en) 2007-05-15 2010-02-03 NeuroSearch A/S Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
US7776877B2 (en) 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
WO2009022171A1 (en) 2007-08-13 2009-02-19 Astrazeneca Ab Pyridinyiioxy pyridines as alk5 inhibitors
WO2009067603A1 (en) 2007-11-21 2009-05-28 Bio-Rad Laboratories, Inc. Photoluminescent metal complexes for protein staining
US20100249192A1 (en) 2007-12-11 2010-09-30 Merck Frosst Canada Ltd. Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
PE20091682A1 (es) 2007-12-20 2009-12-04 Astrazeneca Ab Compuestos de carbamoilo como inhibidores de dgat1 190
EP2252615A1 (en) 2008-01-25 2010-11-24 Arena Pharmaceuticals, Inc. Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists
TW201000107A (en) 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
CN102088855A (zh) 2008-05-08 2011-06-08 百时美施贵宝公司 2-芳基甘氨酰胺衍生物
US20110190365A1 (en) 2008-08-14 2011-08-04 Bayer Crop Science Ag Insecticidal 4-phenyl-1H-pyrazoles
GB0818907D0 (en) 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
MX2011004125A (es) 2008-10-21 2011-05-19 Metabolex Inc Agonistas del receptor gpr120 de arilo y usos de los mismos.
CN102239162B (zh) * 2008-12-04 2014-05-28 弗·哈夫曼-拉罗切有限公司 哒嗪酮衍生物
CN102388059B (zh) 2009-02-11 2015-03-04 陶氏益农公司 杀虫组合物
WO2010124097A2 (en) 2009-04-22 2010-10-28 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US8927551B2 (en) 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
WO2011028043A2 (ko) * 2009-09-02 2011-03-10 이화여자대학교 산학협력단 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
WO2011028044A2 (ko) * 2009-09-02 2011-03-10 이화여자대학교 산학협력단 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
US8394858B2 (en) 2009-12-03 2013-03-12 Novartis Ag Cyclohexane derivatives and uses thereof
EP2512466A4 (en) 2009-12-18 2013-07-03 Activesite Pharmaceuticals Inc PRODRUGS OF INHIBITORS OF PLASMATIC KALLICREIN
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
US20130023534A1 (en) 2010-03-26 2013-01-24 Casillas Linda N Pyrazolyl-pyrimidines as kinase inhibitors
WO2011124930A1 (en) 2010-04-08 2011-10-13 Respivert Limited P38 map kinase inhibitors
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
WO2012004293A2 (de) 2010-07-08 2012-01-12 Bayer Cropscience Ag Insektizide und fungizide wirkstoffkombinationen
JP5789888B2 (ja) 2010-11-01 2015-10-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成のベンゾイミダゾールインヒビター
JP5847830B2 (ja) 2010-11-10 2016-01-27 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン受容体拮抗薬として有用なラクタム誘導体
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
WO2012080376A1 (en) 2010-12-17 2012-06-21 Syngenta Participations Ag Insecticidal compounds
EP2592154A1 (en) * 2011-11-09 2013-05-15 Cellzome Ag Immobilization products and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
WO2014089364A1 (en) 2012-12-06 2014-06-12 Quanticel Pharmaceuticals, Inc Histone demethylase inhibitors

Similar Documents

Publication Publication Date Title
JP2016501882A5 (US20070167479A1-20070719-C00034.png)
JP2016514159A5 (US20070167479A1-20070719-C00034.png)
JP2016503809A5 (US20070167479A1-20070719-C00034.png)
JP2016503799A5 (US20070167479A1-20070719-C00034.png)
JP2017519781A5 (US20070167479A1-20070719-C00034.png)
JP2017527590A5 (US20070167479A1-20070719-C00034.png)
JP2016536286A5 (US20070167479A1-20070719-C00034.png)
JP2016518328A5 (US20070167479A1-20070719-C00034.png)
JP2017524735A5 (US20070167479A1-20070719-C00034.png)
JP2013537203A5 (US20070167479A1-20070719-C00034.png)
JP2012140436A5 (ja) 物質
JP2009263394A5 (US20070167479A1-20070719-C00034.png)
JP2016501250A5 (US20070167479A1-20070719-C00034.png)
JP2016501221A5 (US20070167479A1-20070719-C00034.png)
JP2013079282A5 (US20070167479A1-20070719-C00034.png)
JP2016515561A5 (US20070167479A1-20070719-C00034.png)
JP2013542218A5 (US20070167479A1-20070719-C00034.png)
JP2012092103A5 (US20070167479A1-20070719-C00034.png)
JP2016531126A5 (US20070167479A1-20070719-C00034.png)
EA201491820A1 (ru) Новые тиенопиримидиновые производные, способы их получения и их терапевтические применения
JP2014513051A5 (US20070167479A1-20070719-C00034.png)
JP2012512863A5 (US20070167479A1-20070719-C00034.png)
JP2011016798A5 (US20070167479A1-20070719-C00034.png)
JP2015199738A5 (US20070167479A1-20070719-C00034.png)
JP2015516419A5 (US20070167479A1-20070719-C00034.png)